Literature DB >> 30133791

Current controversies in urinary tract infections: ICI-RS 2017.

Marcio A Averbeck1, Angela Rantell2, Abigail Ford3, Ruth Kirschner-Hermanns4, Vik Khullar3, Adrian Wagg5, Linda Cardozo2.   

Abstract

AIMS: The current definition of urinary tract infection (UTI) relies on laboratory and clinical findings, which may or may not be relevant, depending upon the patient group under consideration. This report considers the utility of current definitions for UTI in adults with and without underlying neurological conditions in order to identify gaps in current understanding and to recommend directions for research.
METHODS: This is a consensus report of the proceedings of Think Tank TT3: "How do we define and when do we treat UTI in neurological and non-neurological adult patients?" from the annual International Consultation on Incontinence-Research Society (ICI-RS), June 8-10, 2017 (Bristol, UK).
RESULTS: Evidence considering the definitions of UTI in patients with and without neurological diseases was reviewed and synthesized. We examined research on laboratory methods and clinical definitions, focusing on specific cut-off values for the quantification of significant bacteriuria, and leucocyturia. Several areas were identified, mostly related to the lack of evidence-based definitions of significant bacteriuria for different patient groups, as well as uncertainties about the role of inflammatory biomarkers, and non-specific symptoms and signs.
CONCLUSIONS: One of the biggest challenges in clinical practice is to discriminate between asymptomatic bacteriuria and symptomatic UTI. Future research should concentrate on risk factors for developing symptomatic UTI in different patient groups. Targeted investigations for specific populations, such as the frail elderly, and patients with neurogenic bladder dysfunction, are still needed.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bacteriuria; biomarkers; diagnosis; treatment; urinary tract infection

Mesh:

Substances:

Year:  2018        PMID: 30133791     DOI: 10.1002/nau.23563

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

1.  Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.

Authors:  Sudipti Gupta; Janae Preece; Andria Haynes; Brian Becknell; Christina Ching
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 2.  Contemporary management considerations of urinary tract infections for women with spina bifida.

Authors:  Ellen Fremion; Paola Bustillos; Rose Khavari
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 2.894

3.  Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders.

Authors:  Catherine S Forster; Wendy D Haffey; Michael Bennett; Kenneth D Greis; Prasad Devarajan
Journal:  Biomark Insights       Date:  2019-03-15

Review 4.  Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections.

Authors:  Michael Kennelly; Nikesh Thiruchelvam; Márcio Augusto Averbeck; Charalampos Konstatinidis; Emmanuel Chartier-Kastler; Pernille Trøjgaard; Rikke Vaabengaard; Andrei Krassioukov; Birte Petersen Jakobsen
Journal:  Adv Urol       Date:  2019-04-02

Review 5.  Paper and thread as media for the frugal detection of urinary tract infections (UTIs).

Authors:  Amrutha Hasandka; Ankita Ramchandran Singh; Anusha Prabhu; Hardik Ramesh Singhal; M S Giri Nandagopal; Naresh Kumar Mani
Journal:  Anal Bioanal Chem       Date:  2021-10-19       Impact factor: 4.142

6.  Investigation and treatment of asymptomatic bacteriuria in older patients with delirium: a cross-sectional survey of Canadian physicians.

Authors:  Antoine Laguë; Valérie Boucher; Pil Joo; Krishan Yadav; Charles Morasse; Marcel Émond
Journal:  CJEM       Date:  2021-06-28       Impact factor: 2.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.